Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acadia Pharmaceutica
(NQ:
ACAD
)
17.05
-0.03 (-0.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Acadia Pharmaceutica
< Previous
1
2
3
4
5
6
7
8
Next >
3 Biotech Stocks With the Strongest Clinical Pipelines
November 08, 2023
Many industry heavyweights are on the hunt for fresh new ideas -- great news for biotech stocks to buy with strong pipelines.
Via
InvestorPlace
What 7 Analyst Ratings Have To Say About ACADIA Pharmaceuticals
November 06, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 02, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
October 10, 2023
Via
Benzinga
Why Acadia Pharmaceuticals Stock Is Rising Today
October 10, 2023
An analyst upgrade is sparking a rally in the drugmaker's shares today.
Via
The Motley Fool
2 Growth Stocks I'd Buy on the Dip
September 30, 2023
These two growth stocks could be worthwhile buy-and-holds.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
October 17, 2023
Via
Benzinga
Analyst Ratings for ACADIA Pharmaceuticals
October 10, 2023
Via
Benzinga
Analyst Ratings for ACADIA Pharmaceuticals
August 22, 2023
Via
Benzinga
Can This Red-Hot Biotech Stock Keep Beating the Broader Markets?
August 22, 2023
This biotech stock has been on fire in 2023.
Via
The Motley Fool
Electronic Arts To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Tuesday
October 10, 2023
JP Morgan increased ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) price target from $29 to $32. JP Morgan analyst Tessa Romero upgraded the stock from Neutral to Overweight. ACADIA Pharmaceuticals shares...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 28, 2023
Via
Benzinga
2 Supercharged Growth Stocks Billionaires Can't Stop Buying
August 28, 2023
A top hedge fund has been steadily buying these two growth stocks in 2023.
Via
The Motley Fool
Analyst Expectations for ACADIA Pharmaceuticals's Future
August 03, 2023
Via
Benzinga
ACADIA Pharmaceuticals's Earnings: A Preview
August 01, 2023
Via
Benzinga
Why Acadia Pharmaceuticals Stock Is Soaring Today
July 14, 2023
Investors are cheering Acadia's latest news.
Via
The Motley Fool
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 28, 2023
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...
Via
Benzinga
This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street
August 16, 2023
This small-cap biotech might be a hidden gem.
Via
The Motley Fool
JP Morgan Maintains Neutral Rating for ACADIA Pharmaceuticals: Here's What You Need To Know
August 07, 2023
Via
Benzinga
Nasdaq Drops 50 Points; Wells Fargo Earnings Beat Views
July 14, 2023
U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Friday. The Dow traded up 0.30% to 34,498.91 while the NASDAQ fell 0.36% to 14,087. The S&P...
Via
Benzinga
Reassuring Market Adoption of Daybue Fuels Acadia's Strategic Advancements, Analysts Boost Price Targets
July 14, 2023
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ex-North American
Via
Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 14, 2023
Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.
Via
Benzinga
Crude Oil Down 2%; Citigroup Profit Tops Estimates
July 14, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Friday. The Dow traded up 0.31% to 34,501.62 while the NASDAQ rose 0.36% to 14,188.86. The S&P 500, also...
Via
Benzinga
Acadia's Newest Drug Just Obliterated Sales Expectations; Shares Hit Two-Year High
July 14, 2023
The company also expanded its commercial rights to the drug and added another to its line-up.
Via
Investor's Business Daily
UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday
July 14, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Are Acadia Pharmaceuticals Shares Trading Higher Today?
July 14, 2023
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) shares are trading higher after the company expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ex-North American
Via
Benzinga
Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 14, 2023
Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.
Via
Benzinga
Microsoft To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Friday
July 14, 2023
Keybanc boosted the price target for Spotify Technology S.A. (NYSE: SPOT) from $180 to $205. Keybanc analyst Justin Patterson maintained an Overweight rating. Spotify shares rose 0.9% to $172.68 in...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 14, 2023
It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.